Instituto de Salud de Bucaramanga Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2005
NCT00428727
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

garlic (1 trial)

Drugs in Phase 3 Trials (1)

nitric oxide (inomax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetic Foot (Phase 3)

Foot Ulcer (Phase 3)

Metabolic Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2